|
MechanismVaricella-zoster virus gH/gL inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Beijing Zhiren Meibo Biotechnology Co., Ltd.
0 Patents (Medical) associated with Beijing Zhiren Meibo Biotechnology Co., Ltd.
100 Deals associated with Beijing Zhiren Meibo Biotechnology Co., Ltd.
100 Translational Medicine associated with Beijing Zhiren Meibo Biotechnology Co., Ltd.